Rapid Renal Sympathetic Denervation for Resistant Hypertension (RAPID)
Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot™ Ablation System
Sponsor: Meditrial Europe Ltd.
A NA clinical study on Hypertension, Resistant to Conventional Therapy, this trial is completed. The trial is conducted by Meditrial Europe Ltd. and has accumulated 7 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Apr 2019 — Jan 2021 [monthly]
Completed NA
Phase: PHASE2 → NA
▶ Show 2 earlier versions
-
Jun 2018 — Apr 2019 [monthly]
Completed PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
May 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Meditrial Europe Ltd.
- Medtronic - MITG
- Medtronic Endovascular
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Antwerp, Belgium , Auckland, New Zealand , Bonn, Germany , Eindhoven, Netherlands , Frankfurt, Germany , Genk, Belgium , Hamburg, Germany , Heidelberg, Germany , Luxembourg, Luxembourg , Milan, Italy and 4 more locations